Zobrazeno 1 - 10
of 22
pro vyhledávání: '"John U. Que"'
Autor:
Martin H. Schoeni, Paul Marcus, Alois B. Lang, Anna Ruedeberg, Urs B. Schaad, John U. Que, Adrian W. Zuercher, Michael P. Horn
Publikováno v:
FEMS Immunology & Medical Microbiology. 47:302-308
We assessed the serological responses over 10 years to repeated immunization of cystic fibrosis (CF) patients with an O-polysaccharide (OPS)-toxin A conjugate vaccine against Pseudomonas aeruginosa. A retrospective analysis was performed with sera fr
Autor:
John U. Que, Bertrand Lell, Holger Gruss, Pierre-Blaise Matsiegui, Jean-François Faucher, Gerri B. Miller, Rajko Neubauer, Michel A. Missinou, Peter G. Kremsner, Ronnie Binder
Publikováno v:
Clinical Infectious Diseases. 35:1147-1154
A double-blind, placebo-controlled study was conducted to measure the impact of malaria prophylaxis with atovaquone/proguanil (A-P) on the immunogenicity of vaccines against typhoid fever and cholera, Salmonella serotype Typhi Ty21a and Vibrio choler
Autor:
Sam T. Donta, Peter Peduzzi, John U. Que, Apurba K. Bhattacharjee, Stanley J. Cryz, Alan S. Cross, Emil Fürer, Steven M. Opal
Publikováno v:
Vaccine. 17:S13-S21
Gram-negative bacillary sepsis is a leading cause of death among patients hospitalized in intensive care units. While initial clinical studies with the passive administration of anti-endotoxin core-glycolipid (CGL) antibodies for the treatment and pr
Autor:
Emil Fürer, Andrew W. Artenstein, Jerald C. Sadoff, Alan S. Cross, J Stanley Cryz Jr, Terry Fredeking, John U. Que
Publikováno v:
Journal of Infectious Diseases. 170:834-840
Since a limited number of O serogroups account for nearly 70% of bacteremic and meningitic Escherichia coli isolates, a polyvalent vaccine was made by conjugating a Pseudomonas aeruginosa exotoxin A carrier protein to the O polysaccharide of 12 serog
Autor:
John U. Que, Jerald C. Sadoff, Kevin C. Kain, J Pipithkul, H.K. Webster, Janet Wittes, Michael R. Hollingdale, Chansuda Wongsrichanalai, Stanley J. Cryz, John W. Boslego, Gross M, W R Ballou, B. Permpanich, Arthur Brown, Daniel M. Gordon, P. Singharaj, P. Su-archawaratana, K. Krinchai
Publikováno v:
Vaccine. 12:102-108
Thai soldiers were vaccinated with a recombinant protein derived from the central repeat region of the circumsporozoite (CS) protein of Plasmodium falciparum conjugated to Toxin A (detoxified) of Pseudomonas aeruginosa (R32Tox-A) to evaluate its safe
Autor:
John U. Que, David N. Taylor, J B McClain, Alan S. Cross, Robert R. Edelman, Steven S. Wasserman, Jerald C. Sadoff, Stanley J. Cryz
Publikováno v:
Vaccine. 12:1288-1294
A Klebsiella (K) vaccine consisting of 24 capsular polysaccharide antigens and a Pseudomonas aeruginosa (P) vaccine consisting of eight O-polysaccharide antigens conjugated to P toxin A have been developed to prevent sepsis by means of active or pass
Publikováno v:
Journal of Infectious Diseases. 163:1040-1045
O-specific polysaccharide (O-PS) isolated from serotype 18 Escherichia coli lipopolysaccharide (LPS) was covalently coupled to either Pseudomonas aeruginosa toxin A (TA) or or cholera toxin (CT). The conjugates were nontoxic and nonpyrogenic. The con
Autor:
Theodore F. Tsai, Herwig Kollaritsch, Stanley J. Cryz, Christian Herzog, John U. Que, Christian Kunz, Gerhard Wiedermann, C. Bruce Cropp
Publikováno v:
The Journal of Infectious Diseases. 179:522-524
Publikováno v:
The Pediatric infectious disease journal. 23(6)
Cystic fibrosis (CF) almost always leads to chronic airway infection with Pseudomonas aeruginosa. Despite advances in antibiotic therapy, after chronic infection rapid deterioration in lung function occurs, increasing morbidity and mortality. Prevent
Autor:
Robert R. Edelman, John U. Que, Alan S. Cross, Moshe J. Shmuklarsky, Stanley J. Cryz, J.Bruce McClain
Publikováno v:
Vaccine. 19(25-26)
Persistence of intravenous (i.v.) hyperimmune immunoglobulin (100 mg/kg) directed against clinically predominant serotypes of Pseudomonas and Klebsiella in ill, febrile patients was compared to healthy volunteers to determine if ill patients have a d